species bacterium, and method of producing kanamycin

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9133492
SERIAL NO

13642842

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Vectors expressing kanA-kanB-kanK and other kanamycin production-related genes, Streptomyces species recombinant bacteria transformed with the vectors, a method of producing kanamycin antibiotics by the bacteria, and a new kanamycin compound produced by the bacterium are provided. With the use of the recombinant bacteria of the present invention, the direct fermentative biosynthesis of amikacin and tobramycin as semi-synthetic kanamycins is possible, and the yield of kanamycin B as a precursor of the semi-synthetic kanamycin is improved.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
INTRON BIOTECHNOLOGY INCSANGDAEWON-DONG #701-704 JUNGANG INDUSPIA 137 SAGIMAKGOL-RO-JUNGWON-GU SEONGNAM-SI GYEONGGI-DO 13202

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Park, Je Won Goyang-si, KR 4 11
Park, Sung Ryeol Goyang-si, KR 3 9
Sohng, Jae Kyung Asan-si, KR 4 12
Yoon, Yeo Joon Seoul, KR 9 16

Cited Art Landscape

Patent Citation Ranking

Forward Cite Landscape

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Mar 15, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00